Is CDXI or EPRT a better dividend investment in 2026?

CDXI currently yields 2000000.00% with a 5% 5-year dividend growth rate. EPRT yields 3.92% with 5% growth. The better choice depends on your goal: CDXI offers higher current income.

What is the dividend yield difference between CDXI and EPRT?

CDXI has a forward dividend yield of 2000000.00% ($2.00/share annually). EPRT yields 3.92% ($1.21/share annually). The yield gap is 1999996.08 percentage points.

Home › Compare › CDXI vs EPRT

CDXI vs EPRT: Dividend Comparison 2026

CDXI yields 2000000.00% · EPRT yields 3.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CDXI wins by $4.879226400974806e+39M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CDXI

● Live price

2000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.879226400974806e+39M

Annual income

$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00

Full CDXI calculator →

EPRT

● Live price

3.92%

Share price

$30.77

Annual div

$1.21

5Y div CAGR

29%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$63.4K

Annual income

$12,840.73

Full EPRT calculator →

Portfolio growth — CDXI vs EPRT

📍 CDXI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CDXI	EPRT
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CDXI + EPRT cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CDXI pays

EPRT pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CDXI

Annual income on $10K today (after 15% tax)

$170,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr

EPRT

Annual income on $10K today (after 15% tax)

$332.87/yr

After 10yr DRIP, annual income (after tax)

$10,914.62/yr

At 15% tax rate, CDXI beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CDXI + EPRT for your $10,000?

CDXI: 50%EPRT: 50%

100% EPRT50/50100% CDXI

Portfolio after 10yr

$2.439613200487403e+39M

Annual income

$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

CDXI

No analyst data

Altman Z

-91.2

Piotroski

3/9

EPRT

Analyst Ratings

Strong

Buy

Hold

Sell

Consensus: Buy

Price Target

$35.50

+15.4% upside vs current

Range: $33.00 — $37.00

Altman Z

1.8

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CDXI buys

EPRT buys

No recent congressional trades found for CDXI or EPRT in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCDXIEPRT

Forward yield	2000000.00% ✓	3.92%
Annual dividend / share	$2.00 ✓	$1.21
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	29% ✓
Portfolio after 10y	$4.879226400974806e+39M	$63.4K ✓
Annual income after 10y	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓	$12,840.73
Total dividends collected	$4.879195005460081e+39M	$37.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: CDXI vs EPRT ($10,000, DRIP)

Year	CDXI Portfolio	CDXI Income/yr	EPRT Portfolio	EPRT Income/yr	Gap
1← crossover	$200,010,700	$200,000,000.00	$11,205	$505.18	+$200.00M → CDXI
2	$3,738,731,768,458	$3,738,517,757,009.35	$12,672	$682.46	+$3738731.76M → CDXI
3	$65,315,062,866,930,490	$65,311,062,423,938,240.00	$14,490	$930.48	+$65315062866.92M → CDXI
4	$1,066,400,830,062,625,000,000	$1,066,330,942,945,357,500,000.00	$16,786	$1,282.69	+$1066400830062625.00M → CDXI
5	$16,272,182,796,453,826,000,000,000	$16,271,041,747,565,660,000,000,000.00	$19,753	$1,791.56	+$16272182796453826560.00M → CDXI
6	$232,054,240,113,661,900,000,000,000,000	$232,036,828,878,069,680,000,000,000,000.00	$23,677	$2,541.64	+$2.3205424011366188e+23M → CDXI
7	$3,092,799,066,104,688,500,000,000,000,000,000	$3,092,550,768,067,767,400,000,000,000,000,000.00	$29,008	$3,672.99	+$3.0927990661046884e+27M → CDXI
8	$38,524,105,697,352,694,000,000,000,000,000,000,000	$38,520,796,402,351,967,000,000,000,000,000,000,000.00	$36,463	$5,425.08	+$3.8524105697352695e+31M → CDXI
9	$448,468,826,014,798,700,000,000,000,000,000,000,000,000	$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00	$47,238	$8,221.57	+$4.484688260147987e+35M → CDXI
10	$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00	$63,385	$12,840.73	+$4.879226400974806e+39M → CDXI

CDXI vs EPRT: Complete Analysis 2026

CDXI — Stock

Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It offers ZanthoSyn, an inflammatory supplement for health and longevity that provides astaxanthin with enhanced absorption and purity. The company sells ZanthoSyn primarily through e-commerce and wholesale channels. It is also developing CDX-101, an astaxanthin pharmaceutical candidate for cardiovascular inflammation and dyslipidemia, with a target indication of severe hypertriglyceridemia; and CDX-301, a zeaxanthin pharmaceutical candidate for macular degeneration. Cardax, Inc. is based in Honolulu, Hawaii.

Full CDXI Calculator →

EPRT — REIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →

📬

Get this CDXI vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CDXI vs SCHD CDXI vs JEPI CDXI vs O CDXI vs KO CDXI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.